Vineet Laboratories Allots 99.87 Lakh Equity Shares via Rights Issue at ₹30
Vineet Laboratories Limited allotted 99,87,258 equity shares via a rights issue at ₹30 per share on February 02, 2026. This increases the company's paid-up capital to ₹19,20,62,660.
The rights issue results in a significant increase in the number of shares and paid-up capital, which can impact earnings per share and overall financial structure. The amount raised is substantial for the company.
The company successfully completed a rights issue, which typically strengthens its financial position and provides capital for growth. This is viewed positively.
Vineet Laboratories Limited announced the allotment of 99,87,258 Equity Shares of face value ₹10 each, at an issue price of ₹30 per share (including a premium of ₹20 per share). This allotment was made on a rights basis by the Rights Issue Committee of the Board of Directors on February 02, 2026.
The rights issue was conducted pursuant to the terms outlined in the Letter of Offer dated December 17, 2025. The allotment was finalized in consultation with Bigshare Services Private Limited, the Registrar to the Issue, and approved by BSE Limited, the designated stock exchange.
Following this allotment, the company's paid-up share capital has increased. Pre-rights issue, the company had 92,19,008 equity shares totaling ₹9,21,90,080. Post-rights issue, the total number of equity shares is 1,92,06,266, with a paid-up share capital of ₹19,20,62,660.
The Rights Issue Committee meeting commenced at 5:35 PM and concluded at 5:45 PM on February 02, 2026.
What to do with a filing like this
Vineet Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under rights issue. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vineet Laboratories Limited. Read the original for the full detail.